Sponsored
released by
Aton Biotech
11.04.24
Contract Manufacturing
Features
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/Technology Transfer
- Solid Dosage/Creams/Ointments
-
Bio News | Breaking News | Facilities
Vitrian Invests in AmplifyBio’s Ohio Biomanufacturing Facility
Commits to support biomanufacturing in Central Ohio.11.05.24
-
APIs | Breaking News | Facilities
Evotec SE Sells Chemical API Manufacturing Site
All business operations and workforce at Evotec DS in Halle/Westphalia will transition to Monacum Partners and continue business as DAPIN GmbH.11.05.24
-
Breaking News | Facilities
Fujifilm Diosynth Biotechnologies Launches First Phase of Expansion in Denmark
First phase adds six mammalian cell bioreactors, bringing the total capacity at the Hillerød site to 12 x 20,000 L bioreactors.11.05.24
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Drug Development | Facilities | Fill/Finish | Lyophilization
Aton Biotech: Accelerating ADC Success
An exclusive Q&A with Min Park, Chief Business Officer of Aton Biotech.
-
Breaking News | Facilities
Olon Confirms Construction Timeline for New Facility
Installation of the large-scale production plant is nearing completion, with an expected finish date of January 2025.11.04.24
-
Analytical Services | Breaking News | cGMP Manufacture | Drug Development | Fill/Finish | Formulation Development | Industry News
FDA Approves McGuff Pharmaceuticals Facility in Santa Ana, CA
The 86,000-sq.-ft. sterile fill-and-finish manufacturing plant creates new business opportunities in both the CMO and CDMO markets.10.31.24
-
APIs | Breaking News | Industry News
Meitheal Pharma Licenses Biosimilars from Hong Kong King-Friend Industry
To market and distribute oncology medications pegfilgrastim and filgrastim, and fertility drug follitropin alpha in the U.S.10.31.24
-
Bio News | Breaking News | cGMP Manufacture
Elektrofi Secures $112.25M to Scale Biopharma Delivery Technology
The funding will be used to establish Phase 3 and commercial-scale Good Manufacturing Practice (GMP) manufacturing lines.10.31.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Sterling Pharma Solutions Expands GMP ADC Manufacturing Capacity
A new 2,300-sq.-ft. suite at Deeside, UK site will allow clinical-scale manufacturing using reactors up to 500 liters, doubling the site’s capacity10.30.24
-
Breaking News | Facilities
IPP’s UGE Subsidiary Earns National Board 'R' Certificate for Eastover, SC Facility
Marks a major milestone for the IPP Group, which can now perform pressure vessel repair and alteration activities at the South Carolina location.10.30.24
-
Breaking News | Facilities
RTI Surgical Completes $15M Expansion in Alachua, FL
New 5,000 sqft clean room significantly enhances its proprietary Tutoplast Tissue Sterilization Process facility.10.30.24
-
APIs | Breaking News | Industry News
Antheia Fulfills First Commercial Delivery of Thebaine
Continues to progress the development of additional products in its pipeline, including oripavine and scopolamine.10.29.24
-
Bioanalytical Services | Breaking News | Facilities
Ardena Expands Bioanalytical Services in the Netherlands
Investment includes establishing a new bioanalytical lab in Oss, along with additional capacity and new GLP capabilities in Assen.10.29.24
-
Breaking News | cGMP Manufacture | Facilities
MilliporeSigma Invests $76M to Expand Bioconjugation Facility in Missouri
Will grow its ADC manufacturing capabilities and triple existing capacity.10.29.24
-
Breaking News | Facilities
Sai Life Sciences Receives EIRs from FDA for India Facilities
Reflects Sai Life Sciences’ commitment to maintaining the highest standards of quality and compliance across its R&D and manufacturing facilities.10.28.24
-
Breaking News | Collaborations & Alliances | Scale-up/Technology Transfer
Chime Biologics, MedPacto Partner to Accelerate Biologics Development & Manufacturing
Aims to streamline the process from tech transfer to cGMP clinical manufacturing for IND submissions.10.28.24
-
Biologics, Proteins, Vaccines | cGMP Manufacture
Biopharma CDMO Discusses Investments and Shares Industry Insight
This past year, Rentschler Biopharma doubled its global cGMP capacity and expanded its cell & gene therapy offering.Online Exclusives Kristin Brooks, Managing Editor, Contract Pharma 10.23.24
-
Breaking News | Facilities | R&D
SwRI Breaks Ground on New Clinical Supply Facility
Will provide three new Current Good Manufacturing Practices pilot plant suites and quality control labs all under one roof.10.23.24
-
Formulation Development | Solid Dosage/Creams/Ointments
Digital Solutions to Overcome Complexities in Oral Solid Dose Drug Formulations
Predictive modeling can create efficiencies and informed decision-making in early development to help combat solubility and bioavailability challenges.Sanjay Konagurthu, Senior Director of Science and Innovation, Pharma Services, Thermo Fisher Scientific 10.23.24
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Drug Development | Industry News
Northway Biotech Adds Gene Therapy CDMO Capabilities in Vilnius, Lithuania
To offer viral vector and plasmid cGMP manufacturing, cell banking and full characterization, and analytical and quality testing.10.22.24
